Centhaquine Citrate is a novel, first-in-class resuscitative agent classified as an anticholinesterase compound, primarily indicated for the treatment of hypovolemic shock resulting from severe blood or… Read more
Centhaquine Citrate is a novel, first-in-class resuscitative agent classified as an anticholinesterase compound, primarily indicated for the treatment of hypovolemic shock resulting from severe blood or fluid loss. By inhibiting acetylcholinesterase, this agent increases acetylcholine levels at cholinergic synapses to enhance cardiac contractility and improve vascular tone during critical emergency situations. To support rigorous drug development and regulatory compliance, this category provides high-quality reference standards for Centhaquine Citrate active pharmaceutical ingredient (API), alongside a comprehensive selection of pharmacopeial and non-pharmacopeial impurities. These compounds, including stable isotope labelled analogues, are essential tools for pharmaceutical laboratories performing impurity profiling, method validation, and ongoing quality control. Utilizing these characterized standards ensures accuracy in analytical testing procedures, allowing researchers to monitor degradation pathways and verify the safety and efficacy of the drug substance throughout the manufacturing process.